Dr. Schrage is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
550 17th Ave
Ste 300
Seattle, WA 98122Phone+1 425-697-3400Fax+1 425-672-2440
Education & Training
University of WashingtonFellowship, Gastrointestinal Pathology, 2016 - 2017- University of WashingtonResidency, Pathology-Anatomic and Clinical, 2012 - 2016
Tulane University School of MedicineClass of 2012
University of California, Los AngelesPhD, Cellular and Molecular Pathology, 2001 - 2008- University of California, Los AngelesBS, Physics, 1996 - 2000
Certifications & Licensure
AK State Medical License 2018 - 2026
CA State Medical License 2018 - 2025
ID State Medical License 2018 - 2025
OR State Medical License 2018 - 2025
WA State Medical License 2014 - 2025- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
Publications & Presentations
PubMed
- 70 citationsFormation of B and T cell subsets require the cannabinoid receptor CB2.David Ziring, Bo Wei, Peter Velazquez, Matthew Schrage, Nancy E. Buckley
Immunogenetics. 2006-08-19 - 52 citationsAntibody-based profiling of the phosphoinositide 3-kinase pathway in clinical prostate cancerGeorge Thomas, Steve Horvath, Bradley L. Smith, Katherine Crosby, Lori A. Lebel
Clinical Cancer Research. 2004-12-15 - 133 citationsProstate Stem Cell Antigen Is Overexpressed in Human Transitional Cell CarcinomaNordine Amara, Ganesh S. Palapattu, Matthew Schrage, Zhennan Gu, George Thomas
Cancer Research. 2001-06-15
Professional Memberships
- Member
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
